Egnyte: eTMF solution
Egnyte has launched Egnyte for Life Sciences eTMF, designed to simplify trial master file processes and facilitate regulatory compliance. The 21 CFR Part 11 compliant solution reportedly reduces document processing time and aids in maintaining compliance and audit readiness.
“In the US alone, the number of registered studies this year has already surpassed the high-water mark set in 2020, and we have not even entered the fourth quarter,” said Egnyte chief product officer Ramin Farassat. “Designed to meet the needs of the growing class of emerging and midsize biosciences companies, Egnyte’s eTMF solution will alleviate the data management burdens associated with trial studies, so that clinical teams can focus on their core mission – getting safe and effective treatments to market quickly.”
